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get medical insurance, but because of the 
pre-existing condition, his application was 
denied by many insurance companies and he 
was unable to afford a high deductible of an 
alternative insurance. Finally, he applied to 
our clinic for pro bono care, was treated with 
modern medications (Uloric and Colcrys). 
His condition significantly improved, pain 
subsided, and he was able to continue his 
personal life and professional career.
Since this patient lacked adequate health-
care coverage, we decided to treat him on 
a pro bono basis at our clinic in Minnesota. 
At present, Minnesota has embraced the 
Affordable Health Care Act more ambi-
tiously than any other state. We expect that 
160,000 more Minnesotans will receive 
health insurance by 2014.
We also see universal health coverage 
being evaluated at the international level 
with the World Health Organization’s stated 
goal “to ensure that all people obtain the 
health services they need – prevention, 
promotion, treatment, rehabilitation, and 
palliation – without risk of financial ruin 
or impoverishment, now and in the future.” 
Among the findings by WHO in its World 
Health Report 2013 “Research for Universal 
Health Coverage” was that conditions caus-
ing ill-health, and the financial capacity to 
protect people from ill-health, vary among 
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Gout is a relatively rare disease that generally 
occurs in the middle-aged population. It is 
usually mild, well controlled using modern 
medication, and rarely causes significant 
joint deformities. Occasionally, the clinical 
course of gout might be severe, leading to 
severe joint deformity, chronic pain, and 
prominent functional decline. However, the 
disease is more pronounced in Asian patients; 
so-called “slow metabolizers,” and in young 
men with a strong genetic predisposition.
Here is the story of a 30-year-old Asian 
patient with a family history of Gout. He 
has suffered from severe gout beginning as 
a teenager, and continuing for nearly two 
decades. He is a 30-year-old Hmong male 
who arrived at our clinic with complaints of 
chronic pain, severe feet and hands deform-
ity, and history of multiple gout flares. Other 
than that, the patient was healthy.
The patient’s father’s brother suffered 
from gout as well, but had less prominent 
joints deformities. The patient’s mom has 
a long history of nephrolithiasis. She had 
undergone surgical removal of about a 2′ 
long renal calculus once.
The patient first had pain in his ankles at 
age 16. At the time he was an avid athlete and 
attributed joint pain to the sports injury. The 
pain subsided after Tylenol and Ibuprofen, but 
he continued having monthly intermittent 
attacks of swelling, redness, and severe pain 
in his feet, then his ankles, and then his hands. 
Gradually, he started having swelling and tophi 
in the first metatarsophalangeal joints of both 
feet. His left foot is shown in Figure 1. Tophi 
then started in the second and fourth meta-
carpophalangeal joints, appearing later on in 
his elbows, and in his knees. He presented with 
excruciating joint pain to the E.R repeatedly, 
and finally he was diagnosed with gout.
He was advised to have a preventive 
gout treatment, but because of the lack of 
medical insurance he had neither treatment, 
nor prophylaxis. The patient attempted to 
countries, and that each nation must 
 determine its own priorities: World report 
2013, Research for universal health cover-
age, World Health Organization, 2013.
While we applaud our efforts in our own 
backyard, and look forward to the much 
anticipated results of hard fought political 
battles in health-care reform, we as physi-
cians will need to continue to wear many 
hats including that of the provider of life-
saving services to those in need, the voice of 
reform and at times the hat of the politician.
We hope that Affordable Care Act will 
bring an end to health-care disparities in our 
country and allow sick people equal access to 
affordable medical care. It will prevent severe 
debilitating cases like this one and develop-
ment of chronic disease complications.
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Figure 1 | Severe feet deformities and tophi accumulation.
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